A lack of developed science has highlighted the difficulty of speeding up pandemic vaccine development, such as for Zika and Ebola, FDA officials and industry representatives say.
Luciana Borio, FDA’s acting chief scientist, said the issue has been evident as an obstacle for sponsors in obtaining accelerated...







